Download PDF
Synlett 2011(14): 2005-2008  
DOI: 10.1055/s-0030-1261172
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

A Novel Short-Step Synthesis of New Xanthenedione Derivatives from the Cyclization of 3-Cinnamoyl-2-styrylchromones

Diana C. G. A. Pintoa, Ana M. L. Secaa,b, Stéphanie B. Leala, Artur M. S. Silva*a, José A. S. Cavaleiroa
a Department of Chemistry & QOPNA, University of Aveiro, 3810-193 Aveiro, Portugal
Fax: +351(234)370084; e-Mail: artur.silva@ua.pt; e-Mail: diana@ua.pt;
b DCTD, University of Azores, 9501-801 Ponta Delgada, Azores
Further Information

Publication History

Received 13 June 2011
Publication Date:
10 August 2011 (online)

    Permissions and Reprints All articles of this category

Abstract

Novel (E)-3-aryl-4-benzylidene-8-hydroxy-3,4-dihydro-1H-xanthene-1,9(2H)-diones are prepared by the cyclization of (E,E)-3-cinnamoyl-5-hydroxy-2-styrylchromones efficiently catalyzed with boron tribromide. The (E,E)-3-cinnamoyl-5-hydroxy-2-styrylchromones are obtained from the Baker-Venkataraman rearrangement of (E,E)-2-acetyl-1,3-phenylene bis(3-phenylacrylate), which is greatly improved under microwave irradiation.

Key words

xanthenediones - 3-cinnamoyl-5-hydroxy-2-styrylchro­mones - microwave irradiation - cyclization - boron tribromide

    References and Notes

  • 1a Roberts JC. Chem. Rev.  1961,  38:  591 
    Google Scholar
  • 1b Gales L. Damas AM. Curr. Med. Chem.  2005,  12:  2499 
    Google Scholar
  • 2 Park HH. Park Y.-D. Han J.-M. Im K.-R. Lee BW. Jeong IY. Jeong T.-S. Lee WS. Bioorg. Med. Chem. Lett.  2006,  16:  5580 
    CrossrefGoogle Scholar
  • 3a Shadid KA. Shaari K. Abas F. Israf DA. Hamzah AS. Syakroni N. Saha K. Lajis NHj. Phytochemistry  2007,  68:  2537 
    Google Scholar
  • 3b Ee GCL. Daud S. Izzaddin SA. Rahmani M. J. Asian Nat. Prod. Res.  2008,  10:  475 
    Google Scholar
  • 4 Suvarnakuta P. Chaweerungrat C. Devahastin S. Food Chem.  2011,  125:  240 
    CrossrefGoogle Scholar
  • 5 Chiang Y.-M. Kuo Y.-H. Oota S. Fukuyama Y. J. Nat. Prod.  2003,  66:  1070 
    CrossrefGoogle Scholar
  • 6 Azebaze AGB. Meyer M. Valentin A. Nguemfo EL. Fomum ZT. Nkengfack AE. Chem. Pharm. Bull.  2006,  54:  111 
    CrossrefPubMedGoogle Scholar
  • 7 An TY. Hu LH. Chen ZL. Chin. Chem. Lett.  2002,  13:  623 
    Google Scholar
  • 8a Brito-Arias M. Tapia-Albarrán M. Padilla-Martínez I. Martínez-Martínez F. Espinosa G. Molins E. Espinosa E. J. Chem. Crystallogr.  1999,  29:  759 
    Google Scholar
  • 8b Karthikeyan G. Pandurangan A. J. Mol. Catal. A: Chem.  2009,  311:  36 
    Google Scholar
  • 8c Pore DM. Shaikh TS. Patil NG. Dongare SB. Desai UV. Synth. Commun.  2010,  40:  2215 
    Google Scholar
  • 9 Gabbutt CD. Hepworth JD. Urquhart MWJ. Miguel LMV. J. Chem. Soc., Perkin Trans. 1  1997,  1819 
    Google Scholar
  • 10a Gerwick WH. Lopez A. Van Duyne GD. Clardy J. Ortiz W. Baez A. Tetrahedron Lett.  1986,  27:  1979 
    Google Scholar
  • 10b Gerwick WH. J. Nat. Prod.  1989,  52:  252 
    Google Scholar
  • 11 Yoon JS. Lee MK. Sung SH. Kim YC. J. Nat. Prod.  2006,  69:  290 
    CrossrefPubMedGoogle Scholar
  • 12 Rocha-Pereira J. Cunha R. Pinto DCGA. Silva AMS. Nascimento MSJ. Bioorg. Med. Chem.  2010,  18:  4195 
    CrossrefGoogle Scholar
  • 13 Gomes A. Fernandes E. Silva AMS. Pinto DCGA. Santos CMM. Cavaleiro JAS. Lima JLFC. Biochem. Pharmacol.  2009,  78:  171 
    CrossrefGoogle Scholar
  • 14 Gomes A. Neuwirth O. Freitas M. Couto D. Ribeiro D. Figueiredo AGPR. Silva AMS. Seixas RSGR. Pinto DCGA. Tomé AC. Cavaleiro JAS. Fernandes E. Lima JLFC. Bioorg. Med. Chem.  2009,  17:  7218 
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Gomes A. Fernandes E. Garcia MBQ. Silva AMS. Pinto DCGA. Santos CMM. Cavaleiro JAS. Lima JLFC. Bioorg. Med. Chem.  2008,  16:  7939 
    CrossrefGoogle Scholar
  • 16 Pinto DCGA. Silva AMS. Cavaleiro JAS. New J. Chem.  2000,  24:  85 
    CrossrefGoogle Scholar
  • 17 Königs P. Neumann O. Kataeva O. Schnakenburg G. Waldvogel S. Eur. J. Org. Chem.  2010,  6417 
    Google Scholar
  • 18 Pinto DCGA. Silva AMS. Cavaleiro JAS. Synlett  2007,  1897 
    Article in Thieme ConnectGoogle Scholar
  • 24a Baker W. J. Chem. Soc.  1933,  1381 
    Google Scholar
  • 24b Gualati KC. Venkataraman K. J. Chem. Soc.  1933,  942 
    Google Scholar
  • 25 Bellur E. Langer P. J. Org. Chem.  2005,  70:  3819 
    CrossrefPubMedGoogle Scholar
19

Optimized Experimental Procedure
A two-necked flask equipped with a magnetic stirring bar, fibre-optic temperature control, and reflux condenser was charged with a mixture of the appropriate (E,E)-2-acetyl-1,3-phenylene bis(3-phenylacrylate) 7a-g (1 mmol) and anhyd K2CO3 (28 mg, 2 mmol) in anhyd pyridine (10 mL) and was then irradiated in an Ethos SYNTH microwave (Milestone Inc.) at constant power of 400 W for 17 min. After this period the reaction mixture was poured onto a mixture of ice (10 g) and H2O (20 mL), and the pH was adjusted to 2 with dilute HCl. The so-formed solids (E,E)-3-cinnamoyl-5-hydroxy-2-styrylchromones 8a-g were filtered off. In the case of compounds 8d and 8f a column chromatography purification, using CH2Cl2 as eluent, was necessary; 8a, 378 mg, 96%; 8b, 409 mg, 97%; 8c, 445 mg, 98%; 8d, 301 mg, 65%; 8e, 422 mg, 93%; 8f, 287 mg, 62%; 8g, 443 mg, 86%.

20

Physical Data of 5-Hydroxy-3′,4′-dimethoxy-3-(3,4-dimethoxycinnamoyl)-2-styrylchromone (8g)
Mp 208-211 ˚C. ¹H NMR (300.13 MHz, CDCl3): δ = 3.93 (s, 4 × 3 H, 3′,4′,3′′,4′′-OCH3), 6.84 (dd, 1 H, J = 0.7, 8.2 Hz, H-6), 6.88 (d, 1 H, J = 8.3 Hz, H-5′′), 6.89 (d, 1 H, J = 8.3 Hz, H-5′), 6.90 (d, 1 H, J = 15.8 Hz, H-α), 7.02 (dd, 1 H, J = 0.7, 8.2 Hz, H-8), 7.07 (d, 1 H, J = 1.8 Hz, H-2′), 7.10 (d, 1 H, J = 15.8 Hz, H-α′), 7.13 (d, 1 H, J = 1.8 Hz,
H-2′′), 7.20 (dd, 2 H, J = 1.8, 8.3 Hz, H-6′,6′′), 7.59 (t, 1 H, J = 8.2 Hz, H-7), 7.62 (d, 1 H, J = 15.8 Hz, H-β′), 7.75 (d, 1 H, J = 15.8 Hz, H-β), 12.50 (s, 1 H, 5-OH) ppm. ¹³C NMR (75.47 MHz, CDCl3): δ = 56.0 (3′,4′,3′′,4′′-OCH3), 106.7 (C-8), 109.9 and 110.1 (C-2′ and/or C-2′′), 110.5 (C-10), 111.0 and 111.1 (C-5′ and/or C-5′′), 111.8 (C-6), 115.1 (C-α), 120.3 (C-3), 123.1 (C-6′), 123.8 (C-6′′), 125.4 (C-α′), 127.3 (C-1′′), 127.8 (C-1′), 135.8 (C-7), 140.7 (C-β), 145.3 (C-β′), 149.2 and 149.3 (C-3′ and/or C-3′′), 151.5 and 151.7 (C-4′ and/or C-4′′), 155.4 (C-9), 161.0 (C-5), 162.6 (C-2), 181.6 (C-4), 190.9 (C=O) ppm. MS (ESI+): m/z (%) = 515 (60) [M + H]+, 537 (100) [M + Na]+, 553 (45) [M + K]+. HRMS (EI): m/z calcd for [C30H26O8]+: 514.1628; found: 514.1639.

21

Optimized Experimental Procedure
A CH2Cl2 solution of BBr3 (2 mmol) was slowly added to a solution of the appropriate (E,E)-3-cinnamoyl-5-hydroxy-2-styrylchromone 8a-g (0.4 mmol) in anhyd CH2Cl2 (20 mL) at low temperature (-78 ˚C). After the addition, the cooling system was removed, and the reaction mixture was stirred at r.t. for 3 h (8 h for 8d and 8f and 22 h for 8g). Then, H2O
(80 mL) was added, and the resulting reaction mixture was stirred at r.t. for 3-4 h. The mixture was extracted with CHCl3 (3 × 80 mL) and the combined extracts evaporated and purified by TLC, using CH2Cl2 as eluent (except in the case of compound 9g which was filtered off): 9a, 99 mg, 63%; 9b, 150 mg, 89%; 9c, 118 mg, 69%; 9d, 95 mg, 51%; 9e, 70 mg, 41%; 9f, 69 mg, 37%; 9g, 148 mg, 81%.

22

Physical Data of ( E )-8-Hydroxy-4-(4-hydroxy-benzylidene)-3-(4-hydroxyphenyl)-3,4-dihydro-1 H -xanthene-1,9 (2 H )-dione (9c)
Mp 319-320 ˚C. ¹H NMR (300.13 MHz, DMSO-d 6): δ = 2.69 (dd, 1 H, J = 2.2, 14.8 Hz, H-2 trans ), 3.23 (dd, 1 H, J = 5.9, 14.8 Hz, H-2 cis ), 4.66 (dd, 1 H, J = 2.2, 5.9 Hz, H-3), 6.72 (br d, 2 H, J = 8.6 Hz, H-3′,5′), 6.83 (d, 2 H, J = 8.7 Hz, H-3′′,5′′), 6.84 (dd, 1 H, J = 0.9, 8.3 Hz, H-7), 7.12 (br d, 2 H, J = 8.6 Hz, H-2′,6′), 7.29 (dd, 1 H, J = 0.9, 8.3 Hz, H-5), 7.37 (d, 2 H, J = 8.7 Hz, H-2′′,6′′), 7.72 (t, 1 H, J = 8.3 Hz, H-6), 8.18 (s, 1 H, H-7′′), 9.57 (s, 1 H, 4′-OH), 10.50 (s, 1 H, 4′′-OH), 12.71 (s, 1 H, 8-OH) ppm. ¹³C NMR (75.47 MHz, DMSO-d 6): δ = 39.2 (C-3), 46.4 (C-2), 107.7 (C-5), 110.4 (C-8a), 111. 9 (C-7), 112.5 (C-9a), 116.0 (C-3′′,5′′), 115.9 (C-3′,5′), 125.2 (C-1′′), 125.7 (C-4), 128.1 (C-2′,6′), 130.8 (C-1′), 132.7 (C-2′′,6′′), 136.4 (C-6), 139.4 (C-7′′), 154.6 (C-4b), 156.5 (C-4′), 160.0 (C-4′′), 160.6 (C-8), 169.9 (C-4a), 179.8 (C-9), 191.8 (C-1) ppm. MS (ESI+): m/z (%) = 427 (15) [M + H]+, 449 (100) [M + Na]+, 465 (10) [M + K]+. HRMS (EI): m/z calcd for [C26H18O6]+: 426.1103; found: 426.1116.

23

Physical Data of ( E )-4-(4-Chlorobenzylidene)-3-(4-chlorophenyl)-8-hydroxy-3,4-dihydro-1 H -xanthene-1,9 (2 H )-dione (9d)
Mp 110-113 ˚C. ¹H NMR (300.13 MHz, CDCl3): δ = 3.05 (dd, 1 H, J = 2.5, 15.5 Hz, H-2 trans ), 3.15 (dd, 1 H, J = 5.6, 15.5 Hz, H-2 cis ), 4.68 (dd, 1 H, J = 2.5, 5.6 Hz, H-3), 6.84 (dd, 1 H, J = 0.6, 8.4 Hz, H-7), 7.02 (dd, 1 H, J = 0.6, 8.4 Hz, H-5), 7.19 (br d, 2 H, J = 8.4 Hz, H-2′,6′), 7.26 (d, 2 H, J = 8.6 Hz, H-2′′,6′′), 7.30 (br d, 2 H, J = 8.4 Hz, H-3′,5′), 7.37 (d, 2 H, J = 8.6 Hz, H-3′′,5′′), 7.59 (t, 1 H, J = 8.4 Hz, H-6), 8.06 (s, 1 H, H-7′′), 12.54 (s, 1 H, 8-OH) ppm. ¹³C NMR (75.47 MHz, CDCl3): δ = 39.8 (C-3), 45.5 (C-2), 106.8 (C-5), 111.0 (C-8a), 112. 9 (C-7), 113.6 (C-9a), 128.3 (C-2′,6′), 129.3 (C-3′′,5′′), 129.6 (C-3′,5′), 129.7 (C-4), 130.7 (C-2′′,6′′), 132.4 (C-1′′), 133.7 (C-4′), 136.2 (C-6 and C-4′′), 137.9 (C-7′′), 138.3 (C-1′), 154.7 (C-4b), 161.7 (C-8), 168.7 (C-4a), 180.0 (C-9), 190.7 (C-1) ppm. MS (ESI+): m/z (%) = 463 (70) [(M + H)+, ³5Cl], 465 (40) [(M + H)+, ³5Cl³7Cl], 467 (7) [(M + H)+, ³7Cl], 485 (75) [(M + Na)+, ³5Cl], 487 (45) [(M + Na)+, ³5Cl³7Cl], 489 (8) [(M + Na)+, ³7Cl], 501 (15) [(M + K)+, ³5Cl], 503 (10) [(M + K)+, ³5Cl³7Cl], 505 (2) [(M + K)+, ³7Cl]. Anal. Calcd (%) for C26H16Cl2O4˙0.5H2O (456.32): C, 66.12; H, 3.63. Found: C, 66.05; H, 3.58. HRMS (EI): m/z calcd for [C26H16 ³5Cl2O4]+: 462.0426; found: 462.0406; m/z calcd for [C26H16 ³5Cl³7ClO4]+: 464.0396; found: 464.0374; m/z calcd for [C26H16 ³7Cl2O4]+: 466.0367; found: 466.0384.